Last Updated on December 21, 2024 by The Health Master
USFDA approval
Alembic Pharmaceuticals has achieved a significant milestone in the US market. The Indian pharmaceutical giant has secured final US Food and Drug Administration approval (USFDA approval) its generic version of Betamethasone Valerate Foam.
This topical medication is used to treat moderate-to-severe psoriasis on the scalp.
A Breakthrough for Scalp Psoriasis Patients
Psoriasis, a chronic autoimmune condition, can cause itchy, red, and scaly patches on the skin.
Scalp psoriasis can be particularly distressing, leading to hair loss and social embarrassment.
Alembic’s generic Betamethasone Valerate Foam offers a much-needed alternative to patients seeking effective treatment for this condition.
Therapeutically Equivalent to Luxiq Foam
The approved ANDA (Abbreviated New Drug Application) for Alembic’s Betamethasone Valerate Foam is therapeutically equivalent to Luxiq Foam (0.12%), a brand-name product marketed by Norvium Bioscience, LLC.
This means that Alembic’s generic version has the same active ingredient, strength, and intended use as the original drug.
Expanding Alembic’s US Presence
This latest USFDA approval further strengthens Alembic Pharmaceuticals’ position in the US market.
The company has a strong track record of developing and manufacturing high-quality generic medications.
With the addition of Betamethasone Valerate Foam to its portfolio, Alembic is poised to expand its reach and provide affordable healthcare solutions to patients across the United States.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA approval granted for Brimonidine Tartrate Ophthalmic Solution: Lupin
USFDA approval granted for Glycopyrrolate Oral Solution
USFDA approval granted for blockbuster drug for Cancer treatment
USFDA approval granted for Valbenazine Capsules
Huge stock of medicines seized: DCA Telangana
FSSAI: Food Labelling and Display – Chapter-9
USFDA issues warning letter to Zydus for injectables unit at Jarod
Streamlining Indian Pharmaceutical Regulatory System: DCGI
Strengthening Drug Regulatory System in India: A Comprehensive Analysis
USFDA approval granted for Brimonidine Tartrate Ophthalmic Solution: Lupin
Revamping the Indian Pharma Supply Chain: A Comprehensive Report
Supreme Court stays notification omitting Misleading Advertisement Rule
Drug recall: Aurobindo, Glenmark, FDC recall drugs due to Quality Issues
CDSCO must maintain a registry of all Brand Name of Drugs: Dr BR Jagashetty
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
